These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 35173531)

  • 1. The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.
    Shen S; Liao Q; Wong YK; Chen X; Yang C; Xu C; Sun J; Wang J
    Int J Biol Sci; 2022; 18(3):983-994. PubMed ID: 35173531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer's Disease.
    Peng X; Fan R; Xie L; Shi X; Dong K; Zhang S; Tao J; Xu W; Ma D; Chen J; Yang Y
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous melatonin restrains neuroinflammation in high fat diet induced diabetic rats through attenuating indoleamine 2,3-dioxygenase 1 expression.
    Maher AM; Saleh SR; Elguindy NM; Hashem HM; Yacout GA
    Life Sci; 2020 Apr; 247():117427. PubMed ID: 32067945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state.
    Korkmaz A; Ma S; Topal T; Rosales-Corral S; Tan DX; Reiter RJ
    Mol Cell Endocrinol; 2012 Feb; 349(2):128-37. PubMed ID: 22079284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: Is this a brain specific diabetic condition?
    Rani V; Deshmukh R; Jaswal P; Kumar P; Bariwal J
    Physiol Behav; 2016 Oct; 164(Pt A):259-67. PubMed ID: 27235734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
    J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
    Tumminia A; Vinciguerra F; Parisi M; Frittitta L
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways.
    Wang J; Zhang J; Yu ZL; Chung SK; Xu B
    Ageing Res Rev; 2024 Aug; 99():102416. PubMed ID: 39002644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.
    Litwiniuk A; Bik W; Kalisz M; Baranowska-Bik A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.
    Kamal MA; Priyamvada S; Anbazhagan AN; Jabir NR; Tabrez S; Greig NH
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):338-46. PubMed ID: 24074448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues.
    Candasamy M; Mohamed Elhassan SA; Kumar Bhattamisra S; Hua WY; Sern LM; Binti Busthamin NA; Mohamad Ilni NB; Shun NS; Baohong L; Ya NS; Ying NW
    Panminerva Med; 2020 Sep; 62(3):155-163. PubMed ID: 32208408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin and Oxidative Stress in the Diabetic State: Clinical Implications and Potential Therapeutic Applications.
    Espino J; Rodríguez AB; Pariente JA
    Curr Med Chem; 2019; 26(22):4178-4190. PubMed ID: 29637854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
    Jayaraj RL; Azimullah S; Beiram R
    Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of melatonin in the onset and progression of type 3 diabetes.
    Song J; Whitcomb DJ; Kim BC
    Mol Brain; 2017 Aug; 10(1):35. PubMed ID: 28764741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes.
    Mahboobi H; Golmirzaei J; Gan SH; Jalalian M; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):543-52. PubMed ID: 24365186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.